Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MTC896 Gel in Acne Vulgaris
NCT02293018Phase 2Completed
- Sponsor
- Mimetica
- Start
- Aug 2014
- Primary completion
- Jan 2015
- Modality
- Small Molecules, Modified Peptides, Native Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of MTC-896 in acne vulgaris, sponsored by Mimetica. Started Aug 2014; status: completed.
02
Drugs
MTC-896
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02293018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02293018.